High-Quality Ipamorelin Supplier, Company

1 / 1

High-Quality Ipamorelin Supplier, Company

Ipamorelin API is prepared by high-standard **solid phase peptide synthesis process (SPPS)** and undergoes strict purification and quality testing, suitable for early pipeline use in scientific research and development and pharmaceutical companies. Product features include: Purity ≥99% (HPLC test) No endotoxin, low residual solvent, low metal ion contamination Provide a full set of quality documents: COA, stability study report, impurity spectrum analysis, etc. Customizable gram-level~kilogram-level supply

Send Inquiry

Product Description

Ipamorelin API Overview

Ipamorelin is a synthetic pentapeptide growth hormone releasing peptide (GHRP) composed of five amino acids (Aib-His-D-2-Nal-D-Phe-Lys-NH₂). It is a selective GHSR-1a agonist with the ability to stimulate growth hormone (GH) secretion with high specificity.

Compared with earlier GHRPs (such as GHRP-2 and GHRP-6), Ipamorelin shows better selectivity, safety and pharmacological stability without significantly affecting the levels of other hormones such as cortisol, prolactin or ACTH.

As a highly-regarded peptide API, Ipamorelin is currently widely used in anti-aging research, sports rehabilitation, osteoporosis intervention, postoperative recovery and metabolic function regulation.

Research and Mechanism of Action

Ipamorelin promotes the release of endogenous growth hormone (GH) from the anterior pituitary by selectively activating the growth hormone secretion receptor (GHSR-1a) and mimicking the action of ghrelin. Its main pharmacological mechanisms include:

1. Stimulate GH Secretion

Ipamorelin highly selectively excites GHSR-1a, prompting the pituitary gland to release GH without significantly affecting ACTH or cortisol levels, offering better endocrine safety.

2. Enhance Protein Synthesis & Cell Repair

By increasing IGF-1 levels, it promotes muscle cell anabolism, enhances tissue repair and regeneration, and is suitable for trauma repair, surgical recovery, and anti-muscle atrophy treatment.

3. Improve Metabolism & Fat Distribution

GH has the effects of fat mobilization and insulin sensitivity improvement. Ipamorelin assists in regulating metabolic status and is used in research on metabolic syndrome and obesity intervention.

4. Improve Bone Density & Anti-Aging

The GH/IGF-1 axis promotes bone formation and mineralization. Ipamorelin shows promise in anti-osteoporosis, fracture rehabilitation, and anti-aging research.

5. Improve Circadian Rhythm & Sleep Quality

GH release is usually accompanied by deep sleep. Studies have found that Ipamorelin can indirectly improve sleep structure and enhance physiological recovery ability.

Preclinical Studies & Efficacy Verification

Although still in the preclinical/early clinical stage, Ipamorelin has shown good safety and efficacy in animal and select human studies:

GH levels significantly increased (peaks within 30 min, lasts several hours)
No obvious pro-cortisol or pro-ACTH effects; controllable endocrine impact
Improved muscle mass and strength (especially in elderly animal models)
Accelerated postoperative recovery and tissue repair speed
Increased IGF-1 levels aiding cell repair and antioxidant response

In addition, Ipamorelin combined with other GHRH mimetics (such as CJC-1295) in some studies showed synergistic effects, further enhancing the pulse release of GH.

API Production & Quality Assurance

The Ipamorelin API is prepared using high-standard solid phase peptide synthesis process (SPPS), strictly purified and quality tested, suitable for scientific research and development as well as early pipeline use of pharmaceutical companies.

Purity ≥99% (HPLC test)

No endotoxin, low residual solvent, low metal ion contamination

Full set of quality documents: COA, stability study report, impurity spectrum analysis

Customizable gram-level to kilogram-level supply

Frequently Asked Questions (FAQ)

Q1: What is Ipamorelin API?

Ipamorelin is a synthetic pentapeptide growth hormone releasing peptide (GHRP) composed of five amino acids (Aib-His-D-2-Nal-D-Phe-Lys-NH₂). It acts as a selective GHSR-1a agonist to stimulate growth hormone secretion.

Q2: How does Ipamorelin differ from earlier GHRPs like GHRP-2 and GHRP-6?

Compared to earlier GHRPs, Ipamorelin displays superior selectivity, safety, and pharmacological stability without significantly elevating cortisol, prolactin, or ACTH levels.

Q3: What is the primary mechanism of action of Ipamorelin?

Ipamorelin selectively activates the growth hormone secretion receptor (GHSR-1a) in the anterior pituitary, mimicking ghrelin to stimulate the pulse release of endogenous growth hormone (GH).

Q4: What research fields utilize Ipamorelin API?

It is widely utilized in scientific research focusing on anti-aging, sports rehabilitation, osteoporosis interventions, surgical and trauma recovery, as well as metabolic function regulation.

Q5: Can Ipamorelin be combined with other peptides in research?

Yes, research indicates that combining Ipamorelin with GHRH mimetics like CJC-1295 yields synergistic effects, further optimizing the pulse release of growth hormone.

Q6: What are the main product specifications and quality standards for Ipamorelin API?

The API is manufactured via solid-phase peptide synthesis (SPPS), featuring ≥99% purity by HPLC, low residual solvent, zero endotoxins, complete COA/stability documentation, and scalable supply from gram to kilogram levels.

Product Detail

High-Quality Ipamorelin Supplier, Company